Collegium Pharmaceutical Q3 Adj. EPS $1.96 Beats $1.86 Estimate, Sales $216.339M Miss $217.276M Estimate
Benzinga Newsdesk 5 hours ago
NewsEarningsEarnings BeatsEarnings Misses
Collegium Pharmaceutical (NASDAQ:COLL) reported quarterly earnings of $1.96 per share which beat the analyst consensus estimate of $1.86 by 5.38 percent. This is a 12.89 percent decrease over earnings of $2.25 per share
Collegium Pharmaceutical (NASDAQ:COLL) reported quarterly earnings of $1.96 per share which beat the analyst consensus estimate of $1.86 by 5.38 percent. This is a 12.89 percent decrease over earnings of $2.25 per share from the same period last year. The company reported quarterly sales of $216.339 million which missed the analyst consensus estimate of $217.276 million by 0.43 percent. This is a 3.33 percent increase over sales of $209.361 million the same period last year.